[KYMR] YoY Quarter Result on 30-Sep-2020 [#Q3]

Stock
[KYMR] Kymera Therapeutics, Inc.
Announcement Date
05-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 42.91%
YoY- 30.07%
Quarter Report
KYMR's Result
KYMR's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
Revenue 3,741 4,728 9,551 20,336 14,533 950 31.49%
PBT -62,487 -52,867 -43,002 -28,582 -7,986 -11,420 40.43%
Tax 0 -895 1,916 125 125 445 -
NP -62,487 -52,867 -43,002 -28,582 -7,986 -11,420 40.43%
Tax Rate - - - - - - -
Total Cost 66,228 57,595 52,553 48,918 22,519 12,370 39.82%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
NP Margin -1,670.33 -1,118.17 -450.24 -140.55 -54.95 -1,202.11 6.79%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
EPS -0.82 -0.90 -0.79 -0.56 -0.18 -0.26 25.79%
EPS Diluted -0.82 -0.90 -0.79 -0.56 -0.18 -0.26 25.79%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.